Real-life intraclass switch among IL-17 inhibitors in psoriasis: results from a single-centre, 24-week, retrospective study.

Subjects

Subjects :

Antibodies, Monoclonal, Humanized
Humans
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Interleukin-17
Psoriasis drug therapy

Details

Language :

English

ISSN :

1468-3083

Volume :

36

Issue :

11

Database :

MEDLINE

Journal :

Journal of the European Academy of Dermatology and Venereology : JEADV

Publication Type :

Editorial & Opinion

Accession number :

35770467

Full Text :

https://doi.org/10.1111/jdv.18381